Last reviewed · How we verify
Morte-mescaline
Morte-mescaline is a potent serotonin, norepinephrine, and dopamine reuptake inhibitor.
Morte-mescaline is a potent serotonin, norepinephrine, and dopamine reuptake inhibitor. Used for Treatment-resistant depression.
At a glance
| Generic name | Morte-mescaline |
|---|---|
| Sponsor | Xiangya Hospital of Central South University |
| Drug class | Serotonin-norepinephrine-dopamine reuptake inhibitor |
| Modality | Small molecule |
| Therapeutic area | Psychiatry |
| Phase | FDA-approved |
Mechanism of action
By inhibiting the reuptake of these neurotransmitters, morte-mescaline increases their concentrations in the synaptic cleft, leading to enhanced neurotransmission and associated psychoactive effects.
Approved indications
- Treatment-resistant depression
Common side effects
- Nausea
- Headache
- Dizziness
- Fatigue
- Insomnia
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |